Loading...
•
Dec 31, 2025
Herbalife Q4 2025 Earnings Report
Herbalife reported solid Q4 2025 financial results with net sales growth and adjusted EBITDA above guidance, driven by strong operational momentum and strategic investments.
Key Takeaways
Herbalife concluded 2025 with strong momentum, achieving Q4 net sales of $1.3 billion, a 6.3% year-over-year increase, and adjusted EBITDA of $156.1 million, exceeding guidance. The company also saw significant new distributor growth in North America and Latin America, alongside a strategic investment from Cristiano Ronaldo in its Pro2col technology.
Fourth quarter 2025 net sales reached $1.3 billion, marking a 6.3% increase year-over-year, with a 5.5% rise on a constant currency basis.
Adjusted EBITDA for Q4 2025 was $156.1 million, with an adjusted EBITDA margin of 12.2%, demonstrating strong profitability.
Diluted EPS was $0.81, and adjusted diluted EPS was $0.45 for the fourth quarter.
Cristiano Ronaldo invested $7.5 million for a 10% equity interest in Pro2col Software, highlighting the company's focus on personalized nutrition and wellness technology.
Revenue by Geographic Location
Forward Guidance
Herbalife expects continued growth in 2026, with projected net sales increases and adjusted EBITDA ranging from $670 million to $710 million for the full year, driven by strategic initiatives and platform development.
Positive Outlook
- First quarter 2026 net sales are projected to grow between 3.0% and 7.0% year-over-year.
- Full-year 2026 net sales are expected to increase by 1.0% to 6.0% year-over-year.
- Adjusted EBITDA for Q1 2026 is guided between $155 million and $175 million.
- Full-year 2026 Adjusted EBITDA is projected to be between $670 million and $710 million.
- The company plans to expand Pro2col beta access to additional international markets, starting with select EMEA markets in 2026.
Challenges Ahead
- The company did not provide a reconciliation of forward-looking adjusted EBITDA or constant currency adjusted EBITDA guidance to net income attributable to Herbalife due to the unpredictable nature of certain significant items.
- The outlook is subject to inherent risks and uncertainties, many of which are beyond the company's control.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...